(0350000119) COVID:REALIZZAZIONE OF A RESVERATROL-BASED MOUTHWASH COMPLEXED WITH CYCLODEXTRIN TO PREVENT THE SPREAD OF SARS-COV-2 BY SALIVARY AEROSOLS: PRECLINICAL EXPERIMENTATION (Q4129234): Difference between revisions
Jump to navigation
Jump to search
(Changed label, description and/or aliases in es, and other parts: Adding Spanish translations) |
(Changed label, description and/or aliases in en, and other parts: Adding English translations) |
||||||||||||||
label / en | label / en | ||||||||||||||
(0350000119) COVID:REALIZZAZIONE OF A RESVERATROL-BASED MOUTHWASH COMPLEXED WITH CYCLODEXTRIN TO PREVENT THE SPREAD OF SARS-COV-2 BY SALIVARY AEROSOLS: PRECLINICAL EXPERIMENTATION | |||||||||||||||
Property / summary | |||||||||||||||
(0350000119) COVID:REALIZZAZIONE OF A RESVERATROL-BASED MOUTHWASH COMPLEXED WITH CYCLODEXTRIN TO PREVENT THE SPREAD OF SARS-COV-2 BY SALIVARY AEROSOLS: PRECLINICAL EXPERIMENTATION (English) | |||||||||||||||
Property / summary: (0350000119) COVID:REALIZZAZIONE OF A RESVERATROL-BASED MOUTHWASH COMPLEXED WITH CYCLODEXTRIN TO PREVENT THE SPREAD OF SARS-COV-2 BY SALIVARY AEROSOLS: PRECLINICAL EXPERIMENTATION (English) / rank | |||||||||||||||
Normal rank | |||||||||||||||
Property / summary: (0350000119) COVID:REALIZZAZIONE OF A RESVERATROL-BASED MOUTHWASH COMPLEXED WITH CYCLODEXTRIN TO PREVENT THE SPREAD OF SARS-COV-2 BY SALIVARY AEROSOLS: PRECLINICAL EXPERIMENTATION (English) / qualifier | |||||||||||||||
point in time: 31 January 2022
|
Revision as of 09:01, 31 January 2022
Project Q4129234 in Italy
Language | Label | Description | Also known as |
---|---|---|---|
English | (0350000119) COVID:REALIZZAZIONE OF A RESVERATROL-BASED MOUTHWASH COMPLEXED WITH CYCLODEXTRIN TO PREVENT THE SPREAD OF SARS-COV-2 BY SALIVARY AEROSOLS: PRECLINICAL EXPERIMENTATION |
Project Q4129234 in Italy |
Statements
5,000.0 Euro
0 references
10,000.0 Euro
0 references
50.0 percent
0 references
LOGIDEX SRL
0 references
(0350000119) COVID:REALIZZAZIONE DI UN COLLUTORIO A BASE DI RESVERATROLO COMPLESSATO CON CICLODESTRINE PER PREVENIRE IL DIFFONDERSI DEL SARS-COV-2 MEDIANTE AEROSOL SALIVARE: SPERIMENTAZIONE PRECLINICA (Italian)
0 references
(0350000119) COVID:REALIZZAZIONE DE UN ENJUAGUE BUCAL A BASE DE RESVERATROL COMPLEJO CON CICLODEXTRINA PARA PREVENIR LA PROPAGACIÓN DEL SARS-COV-2 POR AEROSOLES SALIVALES: EXPERIMENTACIÓN PRECLÍNICA (Spanish)
30 January 2022
0 references
(0350000119) COVID:REALIZZAZIONE OF A RESVERATROL-BASED MOUTHWASH COMPLEXED WITH CYCLODEXTRIN TO PREVENT THE SPREAD OF SARS-COV-2 BY SALIVARY AEROSOLS: PRECLINICAL EXPERIMENTATION (English)
31 January 2022
0 references
TORINO
0 references